Using NGAL as an early diagnostic test of acute kidney injury

Renal Failure

Volumn 34, Issue 1, 2012, Pages 130-133

  Smertka, Mike ^a   Chudek, Jerzy ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Acute kidney injury; Early diagnosis; Marker; Neutrophil gelatinase associated lipocalin

Indexed keywords

CREATININE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TROPONIN;

ACUTE KIDNEY FAILURE; ARTICLE; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST; EARLY DIAGNOSIS; HEART INJURY; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; HUMANS; LIPOCALINS; PROTO-ONCOGENE PROTEINS;

EID: 84055184647     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.623500     Document Type: Article

References (35)

1. Devarajan P. Neutrophil gelatinase-associated lipocalin: A promising biomarker for human acute kidney injury. Biomark Med. 2010;4:265-280.
2. Herget-Rosenthal S, Marggraf G, Hüsing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004;66:1115-1122. (Pubitemid 39121017)
3. Ronco C. N-GAL: Diagnosing AKI as soon as possible. Crit Care. 2007;11:173.
4. Flower DR, North AC, Sansom CE. The lipocalin protein family: Structural and sequence overview. Biochim Biophys Acta. 2000;1482:9-24.
5. Uttenthal LO. NGAL: Marker molecule for the distressed kidney. Clin Lab Int. 2005;29:39-41.
6. Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophilassociated lipocalin from humans. Genomics. 1997;45:17-23. (Pubitemid 27449379)
7. Axelsson L, Bergenfeldt N, Ohlsson K. Studies of the release and turnover of a human neutrophil lipocalin. Scand J Clin Lab Invest. 1995;55:577-588.
8. Gwira JA, Wei F, Ishibe S, Ueland JM, Barasch J, Cantley LG. Expression of neutrophil gelitinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem. 2005;280:7875-7882. (Pubitemid 40349684)
9. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14:2534-2543. (Pubitemid 37169339)
10. Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005;115: 610-621. (Pubitemid 40322235)
11. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with sideophore-mediated iron aquisition. Mol Cell. 2002;10:1033-1043. (Pubitemid 36001971)
12. Yang J, Goetz D, Li JY, et al. An iron delivery pathway mediated by a lipocalin. Mol Cell. 2002;10:1045-1056. (Pubitemid 35453824)
13. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4: 337-344.
14. Mitsnefes MM, Kathman TS, Mishra J, et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol. 2007;22:101-108. (Pubitemid 46138368)
15. Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease. Ren Fail. 2008;30:625-628.
16. Soni S, Cruz D, Bobek I, et al. NGAL: A biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol. 2010;42:141-150.
17. Sveger T, Ohlsson K, Mörse H, Polberger S, Laurin S. Plasma neutrophil lipocalin, elastase-alpha 1-antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome. Scand J Clin Lab Invest. 2003;63:89-92. (Pubitemid 36560665)
18. Bagshaw SM, Haase M, Haase-Fielitz A, Bennett M, Devarajan P, Bellomo R. A prospective evaluation of urine microscopy in septic and non-septic acute kidney. Nephrol Dial Transplant. (in press).
19. Allegra A, Alonci A, Bellomo G, et al. Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera. Leuk Lymphoma. 2011;52:101-107.
20. Provatopoulou X, Gounaris A, Kalogera E, et al. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease. BMC Cancer. 2009;9:390.
21. Decavele AS, Dhondt L, De Buyzere ML, Delanghe JR. Increased urinary neutrophil gelatinase associated lipocalin in urinary tract. Clin Chem Lab Med. 2011;49:999-1003.
22. Shavit L, Dolgoker I, Ivgi H, Assous M, Slotki I. Neutrophil gelatinase-associated lipocalin as a predictor of complications and mortality in patients undergoing non-cardiac major surgery. Kidney Blood Press Res. 2011;34:116-124.
23. Haase M, Mertens PR, Haase-Fielitz A. Renal stress in vivo in real time-visualized by the NGAL reporter mouse. Nephrol Dial Transplant. 2011;26(7):2109-2111.
24. Devarajan P. Review: Neutrophil gelatinase-associated lipocalin: A troponin-like biomarker for human acute kidney injury. Nephrology. 2010;15:419-428.
25. Wagener G, Minhaz M, Mattis FA, Kim M, Emond JC, Lee HT. Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation. Nephrol Dial Transplant. 2011;26:1717-1723.
26. Soni SS, Ronco C, Katz N, Cruz DN. Early diagnosis of acute kidney injury: The promise of novel biomarkers. Blood Purif. 2009;28:165-174.
27. Zappitelli M, Washburn KK, Arikan AA, et al. Urine neutrophil gelinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: A prospective cohort study. Crit Care. 2007;11:R84.
28. Siew ED, Ware LB, Gebretsadik T, et al. Urine neutrophil gelitinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol. 2009;20: 1823-1832.
29. Makris K, Markou N, Evodia E, et al. Urinary neutrophil gelitinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med. 2009;47:79-82.
30. Bagshaw SM, Bennett M, Haase M, et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic vs. nonseptic acute kidney injury in critical illness. Intensive Care Med. 2009;36:452-461.
31. Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelitinase-associated lipocalin in diagnosis and prognosis in acute kidney injury: A systemic review and meta-analysis. Am J Kidney Dis. 2009;54:1012-1024.
32. Lavery AP, Meinzen-Derr JK, Anderson E, et al. Urinary NGAL in premature infants. Pediatr Res. 2008;64:423-428.
33. Koyner JL, Bennett MR, Worcester EM, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;74:1059-1069.
34. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase associated lipocalin as a biomarker for acute renal injury following cardiac surgery. Lancet. 2005;365:1231-1238. (Pubitemid 40469655)
35. Sveger T, Ohlsson K, Mörse H, Polberger S, Laurin S. Plasma neutrophil lipocalin, elastase-alpha1-antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome. Scand J Clin Lab Invest. 2003;63:89-92. (Pubitemid 36560665)